Overview
GRDN market data
Price History
GRDN price chart
Valuation & Profitability
- P/E (TTM)
- 47.46 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.78 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.35 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $19.30 – $44.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $2.5K · P/B 9.26 · P/S 1.73.
Company news
Guardian Pharmacy Services Acquires Wellness Concepts; Terms Not DisclosedBenzinga · Jul 1, 2026, 8:40 PM
Guardian Pharmacy Services Appoints CFO David Morris As COO, Effective July 1Benzinga · Jun 22, 2026, 8:35 PM
8-K filing — Guardian Pharmacy Services, Inc. (GRDN)SEC EDGAR · Jun 22, 2026, 8:35 PM
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47Benzinga · Jun 17, 2026, 2:55 PM
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47Benzinga · Jun 17, 2026, 12:05 PM